JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
CALL
Dow Inc
DOW
$20.2B
| $6.14M | ﹤0.01% |
152,900
| – | – |
2020 Q4
16 quarters
|
|
3077
Tronox
TROX
$628M
| $6.13M | ﹤0.01% |
608,948
-232,282
| -28% | -$2.83M |
2015 Q3
37 quarters
|
|
3078
Pitney Bowes
PBI
$2.3B
| $6.12M | ﹤0.01% |
845,832
-121,552
| -13% | -$903K |
2013 Q2
46 quarters
|
|
3079
Invesco DB Commodity Index Tracking Fund
DBC
$1.93B
| $6.12M | ﹤0.01% |
286,271
-19,796
| -6% | -$442K |
2013 Q2
46 quarters
|
|
3080
SGHC Ltd
SGHC
$5.72B
| $6.12M | ﹤0.01% |
981,950
+755,044
| +333% | +$4.03M |
2022 Q4
8 quarters
|
|
3081
PUT
Capital One
COF
$119B
| $6.12M | ﹤0.01% |
34,300
-2,800
| -8% | -$485K |
2023 Q2
6 quarters
|
|
3082
Tower Semiconductor
TSEM
$27.2B
| $6.11M | ﹤0.01% |
118,700
-167,263
| -58% | -$7.83M |
2015 Q4
36 quarters
|
|
3083
IBEX
IBEX
$579M
| $6.11M | ﹤0.01% |
284,292
+264,947
| +1,370% | +$5.21M |
2020 Q3
17 quarters
|
|
|
REVG
3084
DELISTED
REV Group
REVG
| $6.1M | ﹤0.01% |
191,481
+136,700
| +250% | +$4.06M |
2017 Q3
29 quarters
|
|
3085
Lindblad Expeditions
LIND
$2.28B
| $6.1M | ﹤0.01% |
514,214
+191,546
| +59% | +$2.2M |
2017 Q4
28 quarters
|
|
3086
Encore Capital Group
ECPG
$2.03B
| $6.1M | ﹤0.01% |
127,610
+44,364
| +53% | +$2.1M |
2013 Q2
46 quarters
|
|
3087
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.1B
| $6.07M | ﹤0.01% |
45,875
-673,393
| -94% | -$92.1M |
2013 Q2
46 quarters
|
|
|
OPLN
3088
Openlane
OPLN
$4.34B
| $6.07M | ﹤0.01% |
306,038
+166,536
| +119% | +$3.07M |
2013 Q2
46 quarters
|
|
3089
Clough Select Equity ETF
CBSE
$50.7M
| $6.07M | ﹤0.01% |
183,385
+24,593
| +15% | +$806K |
2024 Q1
3 quarters
|
|
3090
PUT
Ball Corp
BALL
$14.9B
| $6.06M | ﹤0.01% |
110,000
-50,000
| -31% | -$3.06M |
2024 Q1
3 quarters
|
|
|
JLQD
3091
Janus Henderson Corporate Bond ETF
JLQD
$15.6M
| $6.05M | ﹤0.01% |
147,376
| – | – |
2021 Q3
13 quarters
|
|
3092
iShares MSCI Global Gold Miners ETF
RING
$2.32B
| $6.05M | ﹤0.01% |
+215,281
| New | +$6.8M |
2024 Q4
0 quarters
|
|
3093
iShares Micro-Cap ETF
IWC
$1.4B
| $6.04M | ﹤0.01% |
46,353
+1,249
| +3% | +$163K |
2017 Q1
31 quarters
|
|
3094
Evolv Technologies
EVLV
$828M
| $6.04M | ﹤0.01% |
1,527,979
+1,467,538
| +2,428% | +$5.15M |
2021 Q3
13 quarters
|
|
3095
PUT
Edwards Lifesciences
EW
$49.1B
| $6.03M | ﹤0.01% |
81,400
+79,600
| +4,422% | +$5.57M |
2023 Q4
4 quarters
|
|
3096
Viasat
VSAT
$9.92B
| $6.01M | ﹤0.01% |
706,792
+424,317
| +150% | +$4.08M |
2016 Q4
32 quarters
|
|
3097
PENN Entertainment
PENN
$1.98B
| $5.98M | ﹤0.01% |
301,767
-837,450
| -74% | -$16.5M |
2015 Q1
39 quarters
|
|
3098
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$702M
| $5.97M | ﹤0.01% |
125,471
+64,842
| +107% | +$3.18M |
2023 Q3
5 quarters
|
|
3099
Cohu
COHU
$3.48B
| $5.97M | ﹤0.01% |
223,548
+22,108
| +11% | +$578K |
2015 Q1
39 quarters
|
|
3100
PUT
Marvell Technology
MRVL
$245B
| $5.96M | ﹤0.01% |
54,000
+52,400
| +3,275% | +$4.86M |
2023 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.